Cisplatin and Jinfukang, combined treatment at low concentrations, enhances cell apoptosis of human lung cancer cells.
Transcriptome profiling analysis revealed that combination of Cisplatin and Jinfukang regulates genes involved in apoptosis-related signaling pathways.
Activation of AIFM2 plays an important role in pro-apoptosis of human lung cancer cells.